You are never too young to start improving your brain health, an Alzheimer's charity says.
Health reporter
Anyone can take the brain check, which has been based on the latest research, to find out how to lower their individual chances of dementia. Numbers are forecast to rise sharply over the coming decades as more people live longer and their risk of dementia goes up with age. Our individual risk of developing dementia is linked to a combination of our age, the genes we inherit and the lifestyle we lead.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study establishes link between music therapy and dementia treatmentTo meet the growing need from caregivers, musical apps designed for people with dementia are hitting the market.
Read more »
Social isolation linked to an increased risk of dementia, new study findsOlder adults who are socially isolated have a 27% higher chance of developing dementia, according to researchers from Johns Hopkins. The findings suggest that simple interventions could be meaningful.
Read more »
Isolated elderly 28 percent more likely to develop dementia than peersOlder people who are socially isolated face a greater chance of developing dementia than do their counterparts who are not socially isolated, according to a study by Johns Hopkins researchers published in the Journal of the American Geriatrics Society.
Read more »
These are the 12 ways you can drastically cut your dementia riskAlzheimer's Research UK's 'Think Brain Health' campaign outlines lifestyle habits that can cut dementia risk. These habits were raised back in 2020, but not every type of dementia is thought to be preventable, with genetics playing a role in many cases
Read more »
HRT May Prevent Alzheimer's in High-Risk WomenHormone replacement therapy introduced early during the menopausal transition may protect against Alzheimer's dementia in women carrying the APOE4 gene, new research suggests.
Read more »
Eisai files for approval of Alzheimer's drug in JapanJapanese drugmaker Eisai Co Ltd said on Monday it had submitted a marketing authorisation application in Japan for its Alzheimer's drug lecanemab, which was recently granted accelerated approval in the United States.
Read more »